Skip to main content
. Author manuscript; available in PMC: 2024 Jul 21.
Published in final edited form as: Lancet. 2022 Sep 5;400(10356):921–972. doi: 10.1016/S0140-6736(22)01273-9

Figure 17: Timeline of medications entering the market for COPD vs cardiovascular disease.

Figure 17:

COPD=chronic obstructive pulmonary disease. SABA=short-acting β agonist. SAMA=short-acting muscarinic antagonist. LABA=long-acting β agonist. LAMA=long-acting muscarinic antagonist. PDE4=phosphodiesterase-4. ACEI=angiotensin-converting enzyme inhibitor. ARB=angiotensin receptor blocker. MRA=mineralcorticoid receptor antagonists. ARNI=angiotensin receptor–neprilysin inhibitor. SGLT2I=sodium-glucose linked transporter 2 inhibitor. CRT=cardiac resynchronisation therapy. ICD=implantable cardioverter defibrillator. CABG=coronary artery bypass graft. LVAD=left-ventricular assisted device. CRT-P=cardiac resynchronisation therapy pacemaker. CRT-D=cardiac resynchronisation therapy defibrillator..